David Hoffmeister - Celanese Lead Independent Director
| CE Stock | USD 75.00 2.10 2.88% |
Director
Mr. David F. Hoffmeister is an Independent Director of the Company. Mr. Hoffmeister served as the Senior Vice President and Chief Financial Officer of Life Technologies Corporationrationration, a global life sciences company, prior to its acquisition by Fisher Scientific Inc. in February 2014. From October 2004 to November 2008, he served as Chief Financial Officer of Invitrogen Corporationrationration, which merged with Applied Biosystems in November 2008 to form Life Technologies Corporationrationration. Before joining Invitrogen, Mr. Hoffmeister spent 20 years with McKinsey Company as a senior partner serving clients in the healthcare, private equity and chemical industries on issues of strategy and organization. From 1998 to 2003, Mr. Hoffmeister was the leader of McKinseys North American chemical practice. Mr. Hoffmeister serves as a director of Glaukos Corporation and member of the audit committee. since 2016.
| Age | 66 |
| Tenure | 8 years |
| Address | 222 West Las Colinas Boulevard, Irving, TX, United States, 75039-5421 |
| Phone | 972 443 4000 |
| Web | https://www.celanese.com |
Celanese Management Efficiency
The company has Return on Asset (ROA) of 0.027 % which means that for every $100 of assets, it generated a profit of $0.027. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.151 %, which means that it produced $0.151 on every 100 dollars invested by current stockholders. Celanese's management efficiency ratios could be used to measure how well Celanese manages its routine affairs as well as how well it operates its assets and liabilities. As of November 22, 2024, Return On Tangible Assets is expected to decline to 0.06. In addition to that, Return On Capital Employed is expected to decline to 0.07. At present, Celanese's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 285.6 M, whereas Non Currrent Assets Other are forecasted to decline to about 329.6 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Sipho Nkosi | Tronox Holdings PLC | 67 | |
| Sharon Spurlin | AdvanSix | 55 | |
| HansUlrich Engel | BASF SE ADR | 64 | |
| Lynn White | Lsb Industries | 67 | |
| Mary Tidlund | Valhi Inc | 63 | |
| Kanna Kitamura | Lsb Industries | 47 | |
| Jonathan Bobb | Lsb Industries | 44 | |
| Todd Karran | AdvanSix | 56 | |
| Richard Sanders | Lsb Industries | 63 | |
| Ginger Jones | Tronox Holdings PLC | 56 | |
| Daniele Ferrari | Huntsman | 58 | |
| Thomas Barry | Valhi Inc | 76 | |
| Paul Huck | AdvanSix | 70 | |
| Peter Johnston | Tronox Holdings PLC | 69 | |
| Brian Jensen | Lsb Industries | N/A | |
| Terri Herrington | Valhi Inc | 64 | |
| Wayne Reaud | Huntsman | 72 | |
| Robert Margetts | Huntsman | 74 | |
| Saori Dubourg | BASF SE ADR | 52 | |
| Daniel Sansone | AdvanSix | 68 | |
| Mary Beckerle | Huntsman | 66 | |
Management Performance
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.027 |
Celanese Leadership Team
Elected by the shareholders, the Celanese's board of directors comprises two types of representatives: Celanese inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Celanese. The board's role is to monitor Celanese's management team and ensure that shareholders' interests are well served. Celanese's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Celanese's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kim Rucker, Independent Director | ||
| Deborah Kissire, Independent Director | ||
| Aaron Mcgilvray, Vice President and Chief Accounting Officer, Principal Accounting officer | ||
| Anne Puckett, Executive Officer | ||
| Michael Sullivan, Deputy President | ||
| John Fotheringham, Senior Vice President - Acetyls | ||
| John Wulff, Independent Director | ||
| Brandon Ayache, Vice Relations | ||
| Mark Murray, Senior Acetyls | ||
| Lori Ryerkerk, Chairman of the Board, President, Chief Executive Officer | ||
| Thomas Kelly, Senior Vice President - Engineered Materials | ||
| Vanessa Dupuis, Chief Human Resource Officer, Senior Vice President | ||
| A Puckett, Senior Vice President, General Counsel, Corporate Secretary | ||
| William Brown, Lead Independent Director | ||
| Jay Ihlenfeld, Independent Director | ||
| Lynne Puckett, Senior Vice President General Counsel, Corporate Secretary | ||
| Jon Mortimer, Senior Manufacturing | ||
| Todd Elliott, Senior Vice President Acetyls | ||
| David Hoffmeister, Lead Independent Director | ||
| Shannon Jurecka, Chief Human Resource Officer, Senior Vice President | ||
| William Cunningham, Vice Relations | ||
| Edward Galante, Lead Independent Director | ||
| Lori BS, President Chairman | ||
| Jean Blackwell, Independent Director | ||
| Rahul Ghai, Independent Director | ||
| Chuck Kyrish, IR Contact Officer | ||
| Scott Richardson, Executive Vice President, Chief Financial Officer | ||
| Anne JD, Executive Officer | ||
| Benita Casey, Chief Accounting Officer, Principal Accounting Officer | ||
| Michael Koenig, Independent Director | ||
| Sameer Purao, Senior Officer | ||
| Ashley Duffie, Senior Counsel | ||
| Kathryn Hill, Independent Director |
Celanese Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Celanese a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.027 | ||||
| Profit Margin | 0.10 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 20.49 B | ||||
| Shares Outstanding | 109.31 M | ||||
| Shares Owned By Insiders | 0.40 % | ||||
| Shares Owned By Institutions | 99.59 % | ||||
| Number Of Shares Shorted | 5.56 M | ||||
| Price To Earning | 5.86 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celanese. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Celanese Stock refer to our How to Trade Celanese Stock guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Specialty Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Celanese. If investors know Celanese will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Celanese listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.88) | Dividend Share 2.8 | Earnings Share 10.04 | Revenue Per Share 95.989 | Quarterly Revenue Growth (0.03) |
The market value of Celanese is measured differently than its book value, which is the value of Celanese that is recorded on the company's balance sheet. Investors also form their own opinion of Celanese's value that differs from its market value or its book value, called intrinsic value, which is Celanese's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Celanese's market value can be influenced by many factors that don't directly affect Celanese's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Celanese's value and its price as these two are different measures arrived at by different means. Investors typically determine if Celanese is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Celanese's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.